- Home
- DAVA vs BCRX Comparison
DAVA vs BCRX Comparison
Compare DAVA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVA
- BCRX
- Stock Information
- Founded
- DAVA 2000
- BCRX 1986
- Country
- DAVA United Kingdom
- BCRX United States
- Employees
- DAVA N/A
- BCRX N/A
- Industry
- DAVA EDP Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DAVA Technology
- BCRX Health Care
- Exchange
- DAVA Nasdaq
- BCRX Nasdaq
- Market Cap
- DAVA 1.8B
- BCRX 1.6B
- IPO Year
- DAVA 2018
- BCRX 1994
- Fundamental
- Price
- DAVA $30.92
- BCRX $7.47
- Analyst Decision
- DAVA Buy
- BCRX Strong Buy
- Analyst Count
- DAVA 12
- BCRX 5
- Target Price
- DAVA $40.09
- BCRX $15.60
- AVG Volume (30 Days)
- DAVA 409.2K
- BCRX 1.7M
- Earning Date
- DAVA 11-12-2024
- BCRX 11-04-2024
- Dividend Yield
- DAVA N/A
- BCRX N/A
- EPS Growth
- DAVA N/A
- BCRX N/A
- EPS
- DAVA 0.16
- BCRX N/A
- Revenue
- DAVA $1,001,724,970.00
- BCRX $412,579,000.00
- Revenue This Year
- DAVA $10.71
- BCRX $38.01
- Revenue Next Year
- DAVA $10.80
- BCRX $19.04
- P/E Ratio
- DAVA $188.63
- BCRX N/A
- Revenue Growth
- DAVA N/A
- BCRX 29.92
- 52 Week Low
- DAVA $23.28
- BCRX $4.03
- 52 Week High
- DAVA $81.06
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- DAVA 68.82
- BCRX 45.79
- Support Level
- DAVA $29.52
- BCRX $7.20
- Resistance Level
- DAVA $31.10
- BCRX $7.62
- Average True Range (ATR)
- DAVA 1.05
- BCRX 0.33
- MACD
- DAVA 0.11
- BCRX -0.01
- Stochastic Oscillator
- DAVA 98.36
- BCRX 25.54
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.